Corona Virus: Global Pandemic Causing World-Wide Shutdown

por Mitchell, Edith P.
Publicado en J Natl Med Assoc (2020)

COVID-19 Innovations: Addressing Rapidly Changing Clinical Needs

por Mitchell, Edith Peterson
Publicado en J Natl Med Assoc (2020)

The National Medical Association 1895-2020: Struggle for Healthcare Equity in the United States of America

por Mitchell, Edith P.
Publicado en J Natl Med Assoc (2020)

Declines in Cancer Screening During COVID-19 Pandemic

por Mitchell, Edith P.
Publicado en J Natl Med Assoc (2020)

COVID-19 and the Cancer Patient: What Every Physician Needs to Know

por Mitchell, Edith Peterson
Publicado en J Natl Med Assoc (2021)

Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.

por Morris, Gloria J., Mitchell, Edith P.
Publicado 2007

Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

por Lacouture, Mario E., Anadkat, Milan, Jatoi, Aminah, Garawin, Tamer, Bohac, Chet, Mitchell, Edith
Publicado en Clin Colorectal Cancer (2017)

Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients

por Sadigh, Gelareh, Gallagher, Kathleen, Obenchain, Jennifer, Benson, Al, Mitchell, Edith, Sengupta, Soma, Carlos, Ruth C
Publicado en J Am Coll Radiol (2019)

A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorecta...

por Hurwitz, Herbert, Mitchell, Edith P., Cartwright, Thomas, Kwok, Ambrose, Hu, Sylvia, McKenna, Edward, Patt, Yehuda Z.
Publicado 2012

Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass

por Wampole, Matthew E., Kairys, John C., Mitchell, Edith P., Ankeny, Martha L., Thakur, Mathew L., Wickstrom, Eric
Publicado 2013

5-YEAR UPDATED RESULTS OF RTOG-0012 RANDOMIZED PHASE II STUDY OF NEOADJUVANT COMBINED MODALITY CHEMORADIATION FOR DISTAL RECTAL CANCER

por Mohiuddin, Mohammed, Paulus, Rebecca, Mitchell, Edith, Hanna, Nader, Yuen, Albert, Nichols, Romaine, Yalavarthi, S, Hayostek, Cherie, Willett, Christopher
Publicado 2013

Determinants of Pain Severity Changes in Ambulatory Patients With Cancer: An Analysis From Eastern Cooperative Oncology Group Trial E2Z02

por Zhao, Fengmin, Chang, Victor T., Cleeland, Charles, Cleary, James F., Mitchell, Edith P., Wagner, Lynne I., Fisch, Michael J.
Publicado 2014

African American Patients’ Psychosocial Support Needs and Barriers to Treatment: Patients’ Needs Assessment

por Davey, Maureen P., Bilkins, Brianna, Diamond, Guy, Willis, Alliric I., Mitchell, Edith P., Davey, Adam, Young, Faith M.
Publicado en J Cancer Educ (2016)

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study

por Burtness, Barbara, Powell, Mark, Catalano, Paul, Berlin, Jordan, Liles, Darla K., Chapman, Andrew E., Mitchell, Edith, Benson, Al B.
Publicado 2016

5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study

por Hecht, J Randolph, Mitchell, Edith P, Yoshino, Takayuki, Welslau, Manfred, Lin, Xun, Chow Maneval, Edna, Paolini, Jolanda, Lechuga, Maria Jose, Kretzschmar, Albrecht
Publicado en Cancer Manag Res (2015)

Impact of ethnicity on the outcome of men with metastatic hormone sensitive prostate cancer

por Bernard, Brandon, Muralidhar, Vinayak, Chen, Yu-Hui, Sridhar, Srikala S., Mitchell, Edith, Pettaway, Curtis A., Carducci, Michael, Nguyen, Paul L., Sweeney, Christopher J.
Publicado en Cancer (2017)

Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers

por Witkiewicz, Agnieszka K, Dasgupta, Abhijit, Sammons, Sara, Er, Ozlem, Potoczek, Magdalena B, Guiles, Fran, Sotgia, Federica, Brody, Jonathan R, Mitchell, Edith P, Lisanti, Michael P
Publicado 2010

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

por Monti, Daniel A., Mitchell, Edith, Bazzan, Anthony J., Littman, Susan, Zabrecky, George, Yeo, Charles J., Pillai, Madhaven V., Newberg, Andrew B., Deshmukh, Sandeep, Levine, Mark
Publicado 2012

Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers

por Odnokoz, Olena, Yu, Pengfei, Peck, Amy R., Sun, Yunguang, Kovatich, Albert J., Hooke, Jeffrey A., Hu, Hai, Mitchell, Edith P., Rui, Hallgeir, Fuchs, Serge Y.
Publicado en Cancer Biol Ther (2020)

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic...

por Poplin, Elizabeth, Feng, Yang, Berlin, Jordan, Rothenberg, Mace L., Hochster, Howard, Mitchell, Edith, Alberts, Steven, O'Dwyer, Peter, Haller, Daniel, Catalano, Paul, Cella, David, Benson, Al Bowen
Publicado 2009